Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization

NCT03805178 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Not activated at Duke

Conditions

Lung Transplant Rejection
Antibody-mediated Rejection

Interventions

DRUG: Belatacept
DRUG: Carfilzomib

Sponsor

Duke University

Collaborators

[object Object]